• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to the Letter to the Editor entitled "Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment Consensuses: A poor or a proper match?".

作者信息

Jukic Ivana, Rusic Doris, Vukovic Jonatan, Modun Darko

机构信息

Department of Gastroenterology and Hepatology, University Hospital of Split, Split, Croatia.

Department of Pharmacy, University of Split School of Medicine, Split, Croatia.

出版信息

Basic Clin Pharmacol Toxicol. 2020 Jul;127(1):8-9. doi: 10.1111/bcpt.13420. Epub 2020 Apr 29.

DOI:10.1111/bcpt.13420
PMID:32306470
Abstract
摘要

相似文献

1
Response to the Letter to the Editor entitled "Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment Consensuses: A poor or a proper match?".对致编辑的信的回复，信的标题为“希腊注册药包与马斯特里赫特V/佛罗伦萨共识及希腊幽门螺杆菌感染治疗共识的相关性：匹配不佳还是恰当匹配？”
Basic Clin Pharmacol Toxicol. 2020 Jul;127(1):8-9. doi: 10.1111/bcpt.13420. Epub 2020 Apr 29.
2
Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment consensuses: A poor or a proper match?希腊注册药品包装与马斯特里赫特V/佛罗伦萨共识及希腊幽门螺杆菌感染治疗共识的相关性：匹配度低还是合适？
Basic Clin Pharmacol Toxicol. 2020 Jul;127(1):6-7. doi: 10.1111/bcpt.13416. Epub 2020 Apr 28.
3
Correlation of registered drug packs with Maastricht V/Florence Consensus Report and national treatment guidelines for management of Helicobacter pylori infection.注册药品包装与马斯特里赫特 V/佛罗伦萨共识报告及国家幽门螺杆菌感染管理治疗指南的相关性。
Basic Clin Pharmacol Toxicol. 2020 Mar;126(3):212-225. doi: 10.1111/bcpt.13322. Epub 2019 Oct 4.
4
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.基于质子泵抑制剂的1周三联疗法治疗失败后幽门螺杆菌对抗生素继发耐药的发生率：一项前瞻性研究
Dig Liver Dis. 2000 Nov;32(8):667-72. doi: 10.1016/s1590-8658(00)80327-8.
5
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.马斯特里赫特II治疗方案及不同质子泵抑制剂根除幽门螺杆菌的疗效
World J Gastroenterol. 2004 Jun 1;10(11):1656-8. doi: 10.3748/wjg.v10.i11.1656.
6
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 IV/佛罗伦萨共识报告。
Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.
7
[Clinical significance of Helicobacter pylori infection].幽门螺杆菌感染的临床意义
Klin Med (Mosk). 2013;91(8):4-12.
8
Pharmacological considerations and step-by-step proposal for the treatment of Helicobacter pylori infection in the year 2018.2018年幽门螺杆菌感染治疗的药理学考量及逐步建议
Minerva Gastroenterol Dietol. 2018 Sep;64(3):310-321. doi: 10.23736/S1121-421X.18.02492-3. Epub 2018 Mar 30.
9
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.基于 vonoprazan 的三联疗法与基于药敏的质子泵抑制剂三联疗法根除幽门螺杆菌的非劣效性研究。
Ann Clin Microbiol Antimicrob. 2018 Jun 28;17(1):29. doi: 10.1186/s12941-018-0281-x.
10
Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial.基于 vonoprazan 与质子泵抑制剂的一线 7 天三联疗法治疗克拉霉素敏感的幽门螺杆菌：一项多中心、前瞻性、随机试验。
Helicobacter. 2018 Apr;23(2):e12456. doi: 10.1111/hel.12456. Epub 2017 Dec 21.

引用本文的文献

1
Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks.新冠疫情对抗菌药物耐药性出现的影响：调整对未来疫情的应对措施。
Life (Basel). 2021 Mar 10;11(3):220. doi: 10.3390/life11030220.
2
Are We Making the Most of Community Pharmacies? Implementation of Antimicrobial Stewardship Measures in Community Pharmacies: A Narrative Review.我们是否充分利用了社区药房？社区药房抗菌药物管理措施的实施：一项叙述性综述。
Antibiotics (Basel). 2021 Jan 11;10(1):63. doi: 10.3390/antibiotics10010063.